Jiangsu Hualan New Pharmaceutical Material Co. Ltd. (301093.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · China

Price
48.90 CNY
Market cap
10.42 bn CNY
P/E (2025)
173.46
P/S (2025)
16.82
Dividend yield
0.10 %
Net margin
9.71 %
Return on equity (ROE)
2.74 %
Return on assets (ROA)
2.36 %

Jiangsu Hualan New Pharmaceutical Material Co. Ltd. financials

Fiscal year20242025
Revenue586.41 m CNY619.45 m CNY
Gross profit227.44 m CNY240.79 m CNY
Operating income40.60 m CNY57.49 m CNY
EBIT58.80 m CNY70.49 m CNY
Net income49.57 m CNY60.18 m CNY
Diluted EPS – continuing operations0.39 CNY0.37 CNY

Full history since 2019, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Jiangsu Hualan New Pharmaceutical Material Co. Ltd.

Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. engages in the research and development, manufacture, and sale of packaging materials for the injectable pharmaceuticals in China and internationally. It offers laminated and conventional rubber stoppers; halogenated butyl polytetrafluoroethylene film rubber stoppers and halogenated butyl polyester film rubber stoppers; and rubber components for pen syringes (cassette vials), assemblies for plastic infusion containers, silicone rubber products, medical devices and accessories, etc. Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. was founded in 1992 and is based in Jiangyin, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.